INO
Inovio Pharmaceuticals Inc
1.20$
-4.1%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -83.0% | +333.6% | +9.1% | -7.6% | +1.3% | -4.2% | -0.2% | +1.1% | +0.6% | -1.1% | +2.7% | – | |
| – | +9.0% | +11.4% | -40.0% | +248.4% | -75.1% | +6.4% | -40.3% | -9.3% | +1.0% | -8.6% | +209,774.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -260.9% | – | – | – | -874.1% | – | – | – | – | |
| – | +16,044,800.0% | -88.9% | +1,171.2% | +7.9% | -100.0% | +5,937,200.0% | -47.9% | +119.7% | +87.6% | -100.0% | -25.0% | – | |
| – | – | +127.6% | -78.0% | +695,958.4% | -100.0% | -100.1% | – | +67.9% | -100.7% | – | +133.2% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +163.1% | -718.2% | – | -98.0% | +4,311.6% | -96.5% | -103.4% | – | +8.9% | -96.5% | +1,698.6% | – | |
| – | – | – | +179.5% | -185.9% | – | -158.7% | – | – | -36.9% | -333.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.